Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

Cited In for PubMed (Select 19151707)

1.

Multifunctional role of ATM/Tel1 kinase in genome stability: from the DNA damage response to telomere maintenance.

Di Domenico EG, Romano E, Del Porto P, Ascenzioni F.

Biomed Res Int. 2014;2014:787404. doi: 10.1155/2014/787404. Epub 2014 Aug 28.

2.

Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency.

Carlessi L, Fusar Poli E, Bechi G, Mantegazza M, Pascucci B, Narciso L, Dogliotti E, Sala C, Verpelli C, Lecis D, Delia D.

Cell Death Dis. 2014 Jul 17;5:e1342. doi: 10.1038/cddis.2014.310.

3.

ROS-PIASγ cross talk channelizes ATM signaling from resistance to apoptosis during chemosensitization of resistant tumors.

Mohanty S, Saha S, Md S Hossain D, Adhikary A, Mukherjee S, Manna A, Chakraborty S, Mazumdar M, Ray P, Das K, Chakraborty J, Sa G, Das T.

Cell Death Dis. 2014 Jan 23;5:e1021. doi: 10.1038/cddis.2013.534.

4.

EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia.

Li J, Hart RP, Mallimo EM, Swerdel MR, Kusnecov AW, Herrup K.

Nat Neurosci. 2013 Dec;16(12):1745-53. doi: 10.1038/nn.3564. Epub 2013 Oct 27. Erratum in: Nat Neurosci. 2014 Sep;17(9):1286.

5.

Synaptic activity bidirectionally regulates a novel sequence-specific S-Q phosphoproteome in neurons.

Siddoway B, Hou H, Yang H, Petralia R, Xia H.

J Neurochem. 2014 Mar;128(6):841-51. doi: 10.1111/jnc.12487. Epub 2013 Nov 13.

6.

The ATM signaling network in development and disease.

Stracker TH, Roig I, Knobel PA, Marjanović M.

Front Genet. 2013 Mar 25;4:37. doi: 10.3389/fgene.2013.00037. eCollection 2013.

7.

Identification and cytoprotective function of a novel nestin isoform, Nes-S, in dorsal root ganglia neurons.

Su PH, Chen CC, Chang YF, Wong ZR, Chang KW, Huang BM, Yang HY.

J Biol Chem. 2013 Mar 22;288(12):8391-404. doi: 10.1074/jbc.M112.408179. Epub 2013 Jan 14.

8.

The role of the DNA damage response kinase ataxia telangiectasia mutated in neuroprotection.

Marinoglou K.

Yale J Biol Med. 2012 Dec;85(4):469-80. Epub 2012 Dec 13. Review.

9.

p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.

Zhang L, Liu W, Szumlinski KK, Lew J.

Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20041-6. doi: 10.1073/pnas.1212914109. Epub 2012 Nov 14.

10.

Neuronal responses to physiological stress.

Kagias K, Nehammer C, Pocock R.

Front Genet. 2012 Oct 26;3:222. doi: 10.3389/fgene.2012.00222. eCollection 2012.

11.

Level of cdk5 expression predicts the survival of relapsed multiple myeloma patients.

Levacque Z, Rosales JL, Lee KY.

Cell Cycle. 2012 Nov 1;11(21):4093-5. doi: 10.4161/cc.21886. Epub 2012 Sep 17. No abstract available.

12.

S-nitrosylation of Cdk5: potential implications in amyloid-β-related neurotoxicity in Alzheimer disease.

Qu J, Nakamura T, Holland EA, McKercher SR, Lipton SA.

Prion. 2012 Sep-Oct;6(4):364-70. doi: 10.4161/pri.21250. Epub 2012 Aug 9.

13.

DNA damage response by single-strand breaks in terminally differentiated muscle cells and the control of muscle integrity.

Fortini P, Ferretti C, Pascucci B, Narciso L, Pajalunga D, Puggioni EM, Castino R, Isidoro C, Crescenzi M, Dogliotti E.

Cell Death Differ. 2012 Nov;19(11):1741-9. doi: 10.1038/cdd.2012.53. Epub 2012 Jun 15.

14.

Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons.

Futatsugi A, Utreras E, Rudrabhatla P, Jaffe H, Pant HC, Kulkarni AB.

Cell Cycle. 2012 Apr 15;11(8):1603-10. doi: 10.4161/cc.20009. Epub 2012 Apr 15.

15.

Calpain-mediated degradation of myocyte enhancer factor 2D contributes to excitotoxicity by activation of extrasynaptic N-methyl-D-aspartate receptors.

Wei G, Yin Y, Li W, Bito H, She H, Mao Z.

J Biol Chem. 2012 Feb 17;287(8):5797-805. doi: 10.1074/jbc.M111.260109. Epub 2012 Jan 3.

16.
17.

The impact of cyclin-dependent kinase 5 depletion on poly(ADP-ribose) polymerase activity and responses to radiation.

Bolin C, Boudra MT, Fernet M, Vaslin L, Pennaneach V, Zaremba T, Biard D, Cordelières FP, Favaudon V, Mégnin-Chanet F, Hall J.

Cell Mol Life Sci. 2012 Mar;69(6):951-62. doi: 10.1007/s00018-011-0811-6. Epub 2011 Sep 16.

18.

S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.

Qu J, Nakamura T, Cao G, Holland EA, McKercher SR, Lipton SA.

Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14330-5. doi: 10.1073/pnas.1105172108. Epub 2011 Aug 15.

19.

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.

Johnson N, Li YC, Walton ZE, Cheng KA, Li D, Rodig SJ, Moreau LA, Unitt C, Bronson RT, Thomas HD, Newell DR, D'Andrea AD, Curtin NJ, Wong KK, Shapiro GI.

Nat Med. 2011 Jun 26;17(7):875-82. doi: 10.1038/nm.2377.

20.

Cdk5: mediator of neuronal development, death and the response to DNA damage.

Zhu J, Li W, Mao Z.

Mech Ageing Dev. 2011 Aug;132(8-9):389-94. doi: 10.1016/j.mad.2011.04.011. Epub 2011 May 11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk